Literature DB >> 24875254

Deep sequencing reveals novel Set7 networks.

Samuel T Keating1, Mark Ziemann, Jun Okabe, Abdul Waheed Khan, Aneta Balcerczyk, Assam El-Osta.   

Abstract

BACKGROUND: Methyl-dependent regulation of transcription has expanded from a traditional focus on histones to encompass transcription factor modulation. While the Set7 lysine methyltransferase is associated with pro-inflammatory gene expression in vascular endothelial cells, genome-wide regulatory roles remain to be investigated. From initial characterization of Set7 as specific for methyl-lysine 4 of H3 histones (H3K4m1), biochemical activity toward non-histone substrates has revealed additional mechanisms of gene regulation.
RESULTS: mRNA-Seq revealed transcriptional deregulation of over 8,000 genes in an endothelial model of Set7 knockdown. Gene ontology identified up-regulated pathways involved in developmental processes and extracellular matrix remodeling, whereas pathways regulating the inflammatory response as well as nitric oxide signaling were down-regulated. Chromatin maps derived from ChIP-Seq profiling of H3K4m1 identified several hundred loci with loss of H3K4m1 at gene regulatory elements associated with an unexpectedly subtle effect on gene expression. Transcription factor network analysis implicated six previously described Set7 substrates in mRNA-Seq changes, and we predict that Set7 post-translationally regulates other transcription factors associated with vascular endothelial gene expression through the presence of Set7 amino acid methylation motifs.
CONCLUSION: We describe a role for Set7 in regulating developmental pathways and response to stimuli (inflammation/immune response) in human endothelial cells of vascular origin. Set7-dependent gene expression changes that occurred independent of H3K4m1 may involve transcription factor lysine methylation events. The method of mapping measured transcriptional changes to transcription factors to identify putative substrates with strong associations to functional changes is applicable to substrate prediction for other broad-substrate histone modifiers.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24875254     DOI: 10.1007/s00018-014-1651-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  51 in total

1.  Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.

Authors:  Jun Okabe; Christian Orlowski; Aneta Balcerczyk; Chris Tikellis; Merlin C Thomas; Mark E Cooper; Assam El-Osta
Journal:  Circ Res       Date:  2012-03-08       Impact factor: 17.367

2.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

Review 3.  Glycemic memories and the epigenetic component of diabetic nephropathy.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

4.  STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion.

Authors:  Krzysztof Sikorski; Stefan Chmielewski; Lukasz Przybyl; Uwe Heemann; Joanna Wesoly; Marcus Baumann; Hans A R Bluyssen
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-23       Impact factor: 4.249

5.  Enhancer-associated H3K4 monomethylation by Trithorax-related, the Drosophila homolog of mammalian Mll3/Mll4.

Authors:  Hans-Martin Herz; Man Mohan; Alexander S Garruss; Kaiwei Liang; Yoh-Hei Takahashi; Kristen Mickey; Olaf Voets; C Peter Verrijzer; Ali Shilatifard
Journal:  Genes Dev       Date:  2012-11-19       Impact factor: 11.361

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

7.  Multiple lysine methylation of PCAF by Set9 methyltransferase.

Authors:  Toshihiro Masatsugu; Ken Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2009-02-07       Impact factor: 3.575

8.  Protein lysine methyltransferase G9a acts on non-histone targets.

Authors:  Philipp Rathert; Arunkumar Dhayalan; Marie Murakami; Xing Zhang; Raluca Tamas; Renata Jurkowska; Yasuhiko Komatsu; Yoichi Shinkai; Xiaodong Cheng; Albert Jeltsch
Journal:  Nat Chem Biol       Date:  2008-04-27       Impact factor: 15.040

9.  Vascular histone deacetylation by pharmacological HDAC inhibition.

Authors:  Haloom Rafehi; Aneta Balcerczyk; Sebastian Lunke; Antony Kaspi; Mark Ziemann; Harikrishnan Kn; Jun Okabe; Ishant Khurana; Jenny Ooi; Abdul Waheed Khan; Xiao-Jun Du; Lisa Chang; Izhak Haviv; Samuel T Keating; Tom C Karagiannis; Assam El-Osta
Journal:  Genome Res       Date:  2014-04-14       Impact factor: 9.043

10.  edgeR: a Bioconductor package for differential expression analysis of digital gene expression data.

Authors:  Mark D Robinson; Davis J McCarthy; Gordon K Smyth
Journal:  Bioinformatics       Date:  2009-11-11       Impact factor: 6.937

View more
  13 in total

1.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

Review 2.  Epigenetic Changes in Diabetes and Cardiovascular Risk.

Authors:  Samuel T Keating; Jorge Plutzky; Assam El-Osta
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

3.  Transcriptional activity of the islet β cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferase Set7/9.

Authors:  Aarthi V Maganti; Bernhard Maier; Sarah A Tersey; Megan L Sampley; Amber L Mosley; Sabire Özcan; Boobalan Pachaiyappan; Patrick M Woster; Chad S Hunter; Roland Stein; Raghavendra G Mirmira
Journal:  J Biol Chem       Date:  2015-02-24       Impact factor: 5.157

4.  Set7 mediated interactions regulate transcriptional networks in embryonic stem cells.

Authors:  Natasha K Tuano; Jun Okabe; Mark Ziemann; Mark E Cooper; Assam El-Osta
Journal:  Nucleic Acids Res       Date:  2016-07-20       Impact factor: 16.971

5.  Planarians SET New Paths for Innate Immune Memory.

Authors:  Samuel T Keating; Niels P Riksen; Mihai G Netea
Journal:  EBioMedicine       Date:  2017-05-05       Impact factor: 8.143

6.  Current perspectives in Set7 mediated stem cell differentiation.

Authors:  Nazanin Karimnia; Haloom Rafehi; Natasha K Tuano; Mark Ziemann; Harikrishnan K N; Jun Okabe; Assam El-Osta
Journal:  Noncoding RNA       Date:  2016-12-04

7.  mitch: multi-contrast pathway enrichment for multi-omics and single-cell profiling data.

Authors:  Antony Kaspi; Mark Ziemann
Journal:  BMC Genomics       Date:  2020-06-29       Impact factor: 3.969

Review 8.  Epigenetics in diabetic nephropathy, immunity and metabolism.

Authors:  Samuel T Keating; Janna A van Diepen; Niels P Riksen; Assam El-Osta
Journal:  Diabetologia       Date:  2017-11-11       Impact factor: 10.122

9.  Silencing Lysine-Specific Histone Demethylase 1 (LSD1) Causes Increased HP1-Positive Chromatin, Stimulation of DNA Repair Processes, and Dysregulation of Proliferation by Chk1 Phosphorylation in Human Endothelial Cells.

Authors:  Martyna Wojtala; Arkadiusz Dąbek; Dorota Rybaczek; Agnieszka Śliwińska; Ewa Świderska; Katarzyna Słapek; Assam El-Osta; Aneta Balcerczyk
Journal:  Cells       Date:  2019-10-07       Impact factor: 6.600

Review 10.  Epigenetics and Trained Immunity.

Authors:  Charlotte D C C van der Heijden; Marlies P Noz; Leo A B Joosten; Mihai G Netea; Niels P Riksen; Samuel T Keating
Journal:  Antioxid Redox Signal       Date:  2017-11-21       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.